May 29, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported on a recently released publication in which the Sequenom MassARRAY® System (for research use only) was used in a groundbreaking independent study that detected the transforming fusion gene EML4/ALK in non-small cell lung cancer. The study was [...]
Smiths Detection unveils High Speed Checked Baggage Scanner
May 29, 2012
London, UK,- Smiths Detection today gave the first public preview of a next-generation, high-speed scanner for screening checked airport baggage for explosives. The new scanner was developed in cooperation with Analogic Corporation. Images and details of the newly named HI-SCAN 10080 XCT, currently being tested by international regulatory agencies, were revealed at an Investor Day [...]
SCIENION introduces a new version of sciFLEXARRAYER S1 for non-contact piezo dispensing
May 29, 2012
Scienion launches the new version of its sciFLEXARRAYER S1 at European Lab Automation in Hamburg, May 30-31. The small compact non-contact piezo dispensing roboter with an increased throughput and versatility offers precise ultra-low volume liquid handling for a variety of applications in multiplexed diagnostics and cellular screening approaches. Dortmund and Berlin, Germany, May 25, 2012: [...]
Implanted Body Bombs can be Detected, says Smiths Detection
May 29, 2012
London, UK, - Explosives surgically implanted or inserted in body cavities by terrorists intent on destroying planes in mid-air can be detected by technology already used to combat contraband threats, the President of Smiths Detection said today. Speaking at an investor event in London, Mal Maginnis said the apparently growing threat from such tactics could [...]
New Research Center to Focus on Mammalian Single Cell Genomics
May 29, 2012
The Broad Institute and Fluidigm Corporation have announced the launch of a new research center dedicated to accelerating the development of research methods and discoveries in mammalian single-cell genomics. The Single-Cell Genomics Center is also expected to act as a hub for collaboration among single-cell genomics researchers in many pioneering fields, including stem cells and [...]
Company Recognized for Outstanding Contributions to the Pharmaceutical Sciences
May 29, 2012
Exton, PA, -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, “Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase [...]
NanoString Technologies Names Bruce Seeley Senior Vice President & General Manager, Diagnostics
May 29, 2012
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Bruce J. Seeley as Senior Vice President & General Manager, Diagnostics. In this role, Mr. Seeley will have responsibility for providing strategic direction and commercial leadership for NanoString’s [...]
May 29, 2012
Oxford Instruments, the supplier of Magnetic Resonance solutions for QA laboratories in the food, agricultural, healthcare, polymer, and energy sectors, will present their latest benchtop EMR and NMR systems at ACHEMA 2012. AffirmoEX™ is an EMR (EPR/ESR) analyser providing free radical and transition metal oxidation state information. Electron Magnetic Resonance (EMR) is a unique technique [...]
NEW In Vivo Electroporation System
May 29, 2012
The New AgilePulse® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications. Patented Pulse Agile™ waveforms consists of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues. [...]
Fluxion™ Biosciences Launches Discovery Services Unit
May 29, 2012
SOUTH SAN FRANCISCO, Calif -- Fluxion Biosciences, a privately held drug discovery tools and services company, announced today that it is launching a Discovery Services business to support growing demand for assay support on Fluxion’s unique cell analysis platforms. The new unit, supported by expanded technical personnel and resources, enables Fluxion to offer a range [...]

